Retail drug sales in year to December 2008
Retail pharmacy drug sales in 13 major markets during the 12 months to December 2008 have reached $440.1 billion, according to IMS Health's Retail Drug Monitor. This is a drop compared with the previous monthly report (Marketletter January 29). The UK remains the only country to experience negative growth for the sixth month running (Marketletters passim). Australia and New Zealand, with a combined market of $8.1 billion, and Latin America at $24.2 billion, were the fastest-expanding regions, growing 10%, the latter improving from 9% in the previous report.
Argentina remains the fastest-expanding market surveyed by IMS, with year-on-year growth at 23% to $3.2 billion, up from 22%. Brazil rose an impressive 12% from 11%, the second-fastest for any single country covered in the survey, reaching $12.4 billion. Mexico maintained 2% growth for $8.5 billion, having been at 6% earlier in 2008.
Japan grows faster than Europe's top five
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze